Emergent BioSolutions (EBS) Operating Expenses (2011 - 2026)
Emergent BioSolutions (EBS) posted Operating Expenses of $359.4 million for Q2 2026, up 146.84% on a QoQ basis from $145.6 million in Q1 2026, and up 158.0% year-over-year from $139.3 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Operating Expenses (2011 - 2026) Analysis & Trends
Emergent BioSolutions has reported Operating Expenses for 16 years, with the latest figure at $359.4 million in Q2 2026.
- On a quarterly basis, Operating Expenses rose 158.0% year-over-year to $359.4 million in Q2 2026; TTM through Jun 2026 was $836.2 million, a 12.23% increase from a year earlier, with the FY2025 full-year figure at $642.8 million, down 44.22% from the prior year.
- Operating Expenses was $359.4 million for Q2 2026 at Emergent BioSolutions, up from $145.6 million in the prior quarter.
- The five-year high for Operating Expenses was $630.8 million in Q2 2023, with the low at $139.3 million in Q2 2025.
- Average Operating Expenses over 5 years is $297.9 million, with a median of $293.2 million recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses tumbled 69.6% in 2025, then surged 158.0% in 2026.
- Over 5 years, Operating Expenses stood at $385.5 million in 2022, then fell by 16.89% to $320.4 million in 2023, then plunged by 36.27% to $204.2 million in 2024, then dropped by 13.52% to $176.6 million in 2025, then jumped by 103.51% to $359.4 million in 2026.
- The last three Operating Expenses figures came in at $359.4 million (Q2 2026), $145.6 million (Q1 2026), and $176.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 8.89 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | -5.98 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 1.21 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 505.13 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 359.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 359.40 Mn |
| Mar 31, 2026 | 145.60 Mn |
| Dec 31, 2025 | 176.60 Mn |
| Sep 30, 2025 | 154.60 Mn |
| Jun 30, 2025 | 139.30 Mn |
| Mar 31, 2025 | 172.30 Mn |
| Dec 31, 2024 | 204.20 Mn |
| Sep 30, 2024 | 229.30 Mn |
| Jun 30, 2024 | 458.20 Mn |
| Mar 31, 2024 | 260.60 Mn |
| Dec 31, 2023 | 320.40 Mn |
| Sep 30, 2023 | 512.60 Mn |
| Jun 30, 2023 | 630.80 Mn |
| Mar 31, 2023 | 311.90 Mn |
| Dec 31, 2022 | 385.50 Mn |
| Sep 30, 2022 | 285.20 Mn |
| Jun 30, 2022 | 314.70 Mn |
| Mar 31, 2022 | 301.10 Mn |
| Dec 31, 2021 | 437.90 Mn |
| Sep 30, 2021 | 363.70 Mn |
API Access
Emergent BioSolutions Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();